Arbidol hydrochloride compatibility study with starchy excipients using DSC, FTIR, TGA-FTIR, and PXRD methods

The broad spectrum of antiviral activity and relatively low toxicity of arbidol hydrochloride have made it an interesting subject of research. Additionally, there is no information available regarding its formulation with various excipients. Another drawback is its hydrophobic nature, which contribu...

Full description

Saved in:
Bibliographic Details
Published inJournal of thermal analysis and calorimetry Vol. 150; no. 6; pp. 4151 - 4164
Main Authors Rojek, Barbara, Bartyzel, Agata, Leyk, Edyta, Plenis, Alina
Format Journal Article
LanguageEnglish
Published Dordrecht Springer Nature B.V 01.03.2025
Subjects
Online AccessGet full text
ISSN1388-6150
1588-2926
DOI10.1007/s10973-025-14056-4

Cover

Loading…
Abstract The broad spectrum of antiviral activity and relatively low toxicity of arbidol hydrochloride have made it an interesting subject of research. Additionally, there is no information available regarding its formulation with various excipients. Another drawback is its hydrophobic nature, which contributes to lower bioavailability in specific drug forms. Therefore, it is necessary to test its mixtures with excipients to identify those that can enhance its solubility in water. For this reason, tests of compatibility/incompatibility of mixtures of arbidol hydrochloride with starchy excipients such as dextrin, polydextrose, and hydroxypropyl starch were carried out using differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), thermogravimetry coupled with Fourier transform infrared spectroscopy (TGA-FTIR), and powder X-ray diffraction (PXRD). Additionally, phase diagrams were developed for arbidol hydrochloride mixtures with starchy polymers, which enabled prediction of the solubility of this active pharmaceutical ingredient (API) in polymers and the mutual miscibility of the ingredients. The study concluded that arbidol hydrochloride may be compatible with dextrin.
AbstractList The broad spectrum of antiviral activity and relatively low toxicity of arbidol hydrochloride have made it an interesting subject of research. Additionally, there is no information available regarding its formulation with various excipients. Another drawback is its hydrophobic nature, which contributes to lower bioavailability in specific drug forms. Therefore, it is necessary to test its mixtures with excipients to identify those that can enhance its solubility in water. For this reason, tests of compatibility/incompatibility of mixtures of arbidol hydrochloride with starchy excipients such as dextrin, polydextrose, and hydroxypropyl starch were carried out using differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), thermogravimetry coupled with Fourier transform infrared spectroscopy (TGA-FTIR), and powder X-ray diffraction (PXRD). Additionally, phase diagrams were developed for arbidol hydrochloride mixtures with starchy polymers, which enabled prediction of the solubility of this active pharmaceutical ingredient (API) in polymers and the mutual miscibility of the ingredients. The study concluded that arbidol hydrochloride may be compatible with dextrin.
Author Bartyzel, Agata
Leyk, Edyta
Rojek, Barbara
Plenis, Alina
Author_xml – sequence: 1
  givenname: Barbara
  orcidid: 0000-0002-4815-9630
  surname: Rojek
  fullname: Rojek, Barbara
– sequence: 2
  givenname: Agata
  surname: Bartyzel
  fullname: Bartyzel, Agata
– sequence: 3
  givenname: Edyta
  surname: Leyk
  fullname: Leyk, Edyta
– sequence: 4
  givenname: Alina
  surname: Plenis
  fullname: Plenis, Alina
BookMark eNotkE9LwzAchoNMcE6_gKeA11V_-dO0PY7NzcFAmT14C22S2oy2mUmH9ttbnaf3Oby8LzzXaNK5ziB0R-CBACSPgUCWsAhoHBEOsYj4BZqSOE0jmlExGZmNLEgMV-g6hAMAZBmQKWoXvrTaNbgetHeqbpy32mDl2mPR29I2th9w6E96wF-2r0csvKoHbL6VPVrT9QGfgu0-8OptOcfrfLuf43yziM5UdBq_vu9XuDV97XS4QZdV0QRz-58zlK-f8uVztHvZbJeLXaQoFX3EOOdQaVKC0LHmpVA0MVybUgmuQKe8EgUHnhoBIsvKUmTEqJKxgmYsAcFm6P48e_Tu82RCLw_u5LvxUTJKEwZMEBhb9NxS3oXgTSWP3raFHyQB-WtVnq3K0ar8syo5-wE-QWtL
Cites_doi 10.1016/j.molliq.2021.118300
10.1002/jps.23992
10.1016/j.ejpb.2012.12.018
10.3389/fphar.2019.00014
10.3390/v14061226
10.1016/j.ajps.2014.07.001
10.1016/j.carbpol.2016.09.094
10.1007/s10765-008-0415-z
10.3390/v13081665
10.1080/03639045.2016.1225755
10.1016/S0144-8617(00)00245-9
10.1524/zkri.2011.1399
10.1016/S0378-5173(01)00801-8
10.3390/v10040184
10.1016/j.molliq.2024.124074
10.1007/s11095-014-1500-6
10.1021/acsomega.1c04866
10.1016/j.ejpb.2016.06.024
10.1016/j.ijpharm.2010.04.037
10.3390/molecules29010264
10.1016/j.carbpol.2022.119680
10.3390/ph14050411
10.1016/j.antiviral.2008.10.009
10.1016/j.ijbiomac.2016.02.030
10.1021/acs.biomac.8b01150
10.3390/pharmaceutics15010226
10.1016/B978-0-444-53242-8.00006-0
10.1016/S0144-8617(02)00259-X
ContentType Journal Article
Copyright Akadémiai Kiadó Zrt 2025.
Copyright_xml – notice: Akadémiai Kiadó Zrt 2025.
DBID AAYXX
CITATION
DOI 10.1007/s10973-025-14056-4
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1588-2926
EndPage 4164
ExternalDocumentID 10_1007_s10973_025_14056_4
GroupedDBID -Y2
.86
.VR
06C
06D
0R~
0VY
1N0
2.D
203
29L
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
4.4
406
408
409
40D
40E
53G
5GY
5QI
5VS
67Z
6NX
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAIKT
AAJBT
AANZL
AAPKM
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYXX
AAYZH
ABAKF
ABBBX
ABBRH
ABBXA
ABDBE
ABDBF
ABDZT
ABECU
ABFSG
ABFTV
ABHLI
ABHQN
ABJNI
ABJOX
ABKCH
ABKTR
ABMNI
ABMQK
ABNWP
ABQBU
ABQSL
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABULA
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACSNA
ACSTC
ACUHS
ACZOJ
ADHIR
ADHKG
ADKNI
ADKPE
ADMLS
ADPHR
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFEXP
AFGCZ
AFHIU
AFLOW
AFOHR
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGQPQ
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHPBZ
AHSBF
AHWEU
AHYZX
AI.
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AIXLP
AJBLW
AJRNO
AJZVZ
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
ATHPR
AXYYD
AYFIA
AYJHY
AZFZN
B-.
B0M
BA0
BDATZ
BGNMA
BSONS
CAG
CITATION
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EAD
EAP
EBLON
EBS
EIOEI
EJD
EMK
EPL
ESBYG
ESX
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ7
GQ8
GXS
H13
HF~
HG5
HG6
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I-F
IAO
IHE
IJ-
IKXTQ
ISR
ITC
ITM
IWAJR
IXC
IXE
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
LAK
LLZTM
M4Y
MA-
MET
MKB
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P9N
PF0
PT4
PT5
QOK
QOR
QOS
R89
R9I
RKA
RNI
RNS
ROL
RPX
RSV
RZC
RZE
RZK
S16
S1Z
S26
S27
S28
S3B
SAP
SCG
SCLPG
SCM
SDH
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
STPWE
SZN
T13
T16
TEORI
TSG
TSK
TSV
TUC
TUS
U2A
UG4
UOJIU
UTJUX
UZXMN
VC2
VFIZW
VH1
W23
W48
W4F
WJK
WK8
YLTOR
Z45
ZE2
ZMTXR
~02
~8M
ABRTQ
ID FETCH-LOGICAL-c226t-34440fd1b06d5d4b6c27e4debc64c0d84f6a4048e60699bb691ecb33a2937063
ISSN 1388-6150
IngestDate Sat Aug 23 12:57:21 EDT 2025
Thu Jul 10 10:10:19 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c226t-34440fd1b06d5d4b6c27e4debc64c0d84f6a4048e60699bb691ecb33a2937063
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ORCID 0000-0002-4815-9630
PQID 3227303610
PQPubID 2043843
PageCount 14
ParticipantIDs proquest_journals_3227303610
crossref_primary_10_1007_s10973_025_14056_4
PublicationCentury 2000
PublicationDate 2025-03-01
PublicationDateYYYYMMDD 2025-03-01
PublicationDate_xml – month: 03
  year: 2025
  text: 2025-03-01
  day: 01
PublicationDecade 2020
PublicationPlace Dordrecht
PublicationPlace_xml – name: Dordrecht
PublicationTitle Journal of thermal analysis and calorimetry
PublicationYear 2025
Publisher Springer Nature B.V
Publisher_xml – name: Springer Nature B.V
References E Stefanis (14056_CR20) 2008; 29
KV Belov (14056_CR6) 2024; 397
B Rojek (14056_CR8) 2024; 29
A Forster (14056_CR23) 2001; 226
MK Anwer (14056_CR27) 2021; 14
VA Eventova (14056_CR5) 2023; 15
DC Novo (14056_CR14) 2022; 292
X Qian (14056_CR4) 2022; 14
N Masina (14056_CR11) 2017; 157
X Li (14056_CR28) 2017; 43
IA Leneva (14056_CR1) 2009; 81
E Assaad (14056_CR12) 2010; 394
Ch Gao (14056_CR15) 2019; 20
J Djuris (14056_CR21) 2013; 84
S Baghel (14056_CR17) 2016; 107
M Maniruzzaman (14056_CR22) 2014; 103
SHM Najafi (14056_CR13) 2016; 87
RM Silverstein (14056_CR29) 2005
AS Narang (14056_CR7) 2009
I Leneva (14056_CR2) 2021; 13
AB Salim (14056_CR10) 2020; 10
RC Rowe (14056_CR9) 2009
M Černá (14056_CR30) 2003; 51
M Kačuráková (14056_CR31) 2001; 44
K Ishino (14056_CR25) 2021; 6
V Chernyshev (14056_CR26) 2011; 226
J Haviernik (14056_CR3) 2018; 10
B Tian (14056_CR16) 2015; 32
L Wang (14056_CR24) 2015; 10
E Leyk (14056_CR18) 2019; 10
Ch Zhang (14056_CR19) 2022; 346
References_xml – volume: 346
  year: 2022
  ident: 14056_CR19
  publication-title: J Mol Liq
  doi: 10.1016/j.molliq.2021.118300
– volume-title: Spectrometric identification of organic compounds
  year: 2005
  ident: 14056_CR29
– volume: 103
  start-page: 1819
  year: 2014
  ident: 14056_CR22
  publication-title: J Pharm Sci
  doi: 10.1002/jps.23992
– volume: 84
  start-page: 228
  year: 2013
  ident: 14056_CR21
  publication-title: Eur J Pharm Biopharm
  doi: 10.1016/j.ejpb.2012.12.018
– volume: 10
  start-page: 14
  year: 2019
  ident: 14056_CR18
  publication-title: Front Prarmacol
  doi: 10.3389/fphar.2019.00014
– volume: 14
  start-page: 1226
  year: 2022
  ident: 14056_CR4
  publication-title: Viruses
  doi: 10.3390/v14061226
– volume: 10
  start-page: 73
  year: 2015
  ident: 14056_CR24
  publication-title: Asian J Pharm Sci
  doi: 10.1016/j.ajps.2014.07.001
– volume: 157
  start-page: 1226
  year: 2017
  ident: 14056_CR11
  publication-title: Carbohydr Polym
  doi: 10.1016/j.carbpol.2016.09.094
– volume: 29
  start-page: 568
  year: 2008
  ident: 14056_CR20
  publication-title: Int J Thermophys
  doi: 10.1007/s10765-008-0415-z
– volume: 13
  start-page: 1665
  year: 2021
  ident: 14056_CR2
  publication-title: Viruses
  doi: 10.3390/v13081665
– volume: 43
  start-page: 151
  year: 2017
  ident: 14056_CR28
  publication-title: Drug Dev Ind Pharm
  doi: 10.1080/03639045.2016.1225755
– volume: 44
  start-page: 291
  year: 2001
  ident: 14056_CR31
  publication-title: Carbohydr Polym
  doi: 10.1016/S0144-8617(00)00245-9
– volume: 10
  start-page: 327
  year: 2020
  ident: 14056_CR10
  publication-title: J Nanostruct
– volume: 226
  start-page: 832
  year: 2011
  ident: 14056_CR26
  publication-title: Z Kristallogr
  doi: 10.1524/zkri.2011.1399
– volume: 226
  start-page: 147
  year: 2001
  ident: 14056_CR23
  publication-title: Int J Pharm
  doi: 10.1016/S0378-5173(01)00801-8
– volume: 10
  start-page: 184
  year: 2018
  ident: 14056_CR3
  publication-title: Viruses
  doi: 10.3390/v10040184
– volume: 397
  year: 2024
  ident: 14056_CR6
  publication-title: J Mol Liq
  doi: 10.1016/j.molliq.2024.124074
– volume: 32
  start-page: 840
  year: 2015
  ident: 14056_CR16
  publication-title: Pharm Res
  doi: 10.1007/s11095-014-1500-6
– volume: 6
  start-page: 32869
  year: 2021
  ident: 14056_CR25
  publication-title: ACS Omega
  doi: 10.1021/acsomega.1c04866
– volume: 107
  start-page: 16
  year: 2016
  ident: 14056_CR17
  publication-title: Eur J Pharm Biopharm
  doi: 10.1016/j.ejpb.2016.06.024
– volume-title: Handbook of pharmaceutical excipients
  year: 2009
  ident: 14056_CR9
– volume: 394
  start-page: 75
  year: 2010
  ident: 14056_CR12
  publication-title: Int J Pharm
  doi: 10.1016/j.ijpharm.2010.04.037
– volume: 29
  start-page: 264
  year: 2024
  ident: 14056_CR8
  publication-title: Molecules
  doi: 10.3390/molecules29010264
– volume: 292
  year: 2022
  ident: 14056_CR14
  publication-title: Carbohydr Polym
  doi: 10.1016/j.carbpol.2022.119680
– volume: 14
  start-page: 411
  year: 2021
  ident: 14056_CR27
  publication-title: Pharmaceuticals
  doi: 10.3390/ph14050411
– volume: 81
  start-page: 132
  year: 2009
  ident: 14056_CR1
  publication-title: Antivir Res
  doi: 10.1016/j.antiviral.2008.10.009
– volume: 87
  start-page: 48
  year: 2016
  ident: 14056_CR13
  publication-title: Int J Biol Macromol
  doi: 10.1016/j.ijbiomac.2016.02.030
– volume: 20
  start-page: 608
  year: 2019
  ident: 14056_CR15
  publication-title: Biomacromol
  doi: 10.1021/acs.biomac.8b01150
– volume: 15
  start-page: 226
  year: 2023
  ident: 14056_CR5
  publication-title: Pharmaceutics
  doi: 10.3390/pharmaceutics15010226
– start-page: 125
  volume-title: Developing solid oral dosage forms: Pharmaceutical theory and practice. Part I- Theories and techniques in the characterization of drug substances and excipients
  year: 2009
  ident: 14056_CR7
  doi: 10.1016/B978-0-444-53242-8.00006-0
– volume: 51
  start-page: 383
  year: 2003
  ident: 14056_CR30
  publication-title: Carbohydr Polym
  doi: 10.1016/S0144-8617(02)00259-X
SSID ssj0009901
Score 2.4185026
Snippet The broad spectrum of antiviral activity and relatively low toxicity of arbidol hydrochloride have made it an interesting subject of research. Additionally,...
SourceID proquest
crossref
SourceType Aggregation Database
Index Database
StartPage 4151
SubjectTerms Bioavailability
Biocompatibility
Dextrin
Differential scanning calorimetry
Excipients
Fourier transforms
Incompatibility
Infrared spectroscopy
Miscibility
Mixtures
Phase diagrams
Polydextrose
Polymers
Solubility
Spectrum analysis
Thermogravimetry
X ray powder diffraction
Title Arbidol hydrochloride compatibility study with starchy excipients using DSC, FTIR, TGA-FTIR, and PXRD methods
URI https://www.proquest.com/docview/3227303610
Volume 150
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbK9gAvaOMiNsbkB97aoDhxnOUxKy0DjSJBJvXNimMHuks7dam07BfxMzm-pGlgIOAljZw2bXy--nzHPt8xQq8LmSQBCSOPSQkBCjAIT_gl8wJS-lRJBYxWC5w_TtjJGf0wjaa93veNrKVVJd4Ud_fqSv7HqtAGdtUq2X-w7Pqm0ADnYF84goXh-Fc2TpdiJheX_W-11Dtf6WQ6qWxaeWWzXmtbP9Zlolca1XVf3Raz65mRtq3MVMHbL0NDYrP3Ji0ie5d6zbkRE0whULRbTd_8hsxqGnllyg64GidGLpfrXwQfbFONPy_O1cXGOkc7kbqs6jsFcPlqxXIuS6i-6I9k3bbo1H24e3rpdv1uJiyCqM3Y6kxY6mxsvUayFtSY8TcEE-sa9dY9uTHZCEWssH49aLu3zH4ZgoGRkA13DoST3usq_EY6ncR6JTvyINSMmJMcdepyTz7x8dnpKc9G0-wB2g4gIAEXsJ2Oj48nbYHnxLfBvXsAJ9ByMs2fvqNLgrocwBCbbAc9dkbEqYXXLuqp-RP0cNhsBPgUXTmY4Q7McAdm2MAMa5hhBzPcwgwbmGGA2QBrYA1wA7EBBqBgDTDsAPYMZeNRNjzx3C4dXgHUvfJCSqlfSiJ8JiNJBSuCWFGpRMFo4csjWrKcgp9QEConiRAsIaoQYZgD0YyBID9HW_PFXL1AOIdgnQqijkSiaAgvcUhoLsOQEAkjR7mH-k2v8Wtbi4W3Vbd1H3PoY276mNM9dNB0LHf_2RsO7ivWpI34-3--_BI9arF7gLaq5Uq9AvpZiUNn-R8974TK
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Arbidol+hydrochloride+compatibility+study+with+starchy+excipients+using+DSC%2C+FTIR%2C+TGA-FTIR%2C+and+PXRD+methods&rft.jtitle=Journal+of+thermal+analysis+and+calorimetry&rft.au=Rojek%2C+Barbara&rft.au=Bartyzel+Agata&rft.au=Leyk+Edyta&rft.au=Plenis+Alina&rft.date=2025-03-01&rft.pub=Springer+Nature+B.V&rft.issn=1388-6150&rft.eissn=1588-2926&rft.volume=150&rft.issue=6&rft.spage=4151&rft.epage=4164&rft_id=info:doi/10.1007%2Fs10973-025-14056-4&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1388-6150&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1388-6150&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1388-6150&client=summon